CSD-CH2(1,8)-NH2

N/A

Report date: 2023/08/28 10:43:44
NME

Base Information

Drug NameCSD-CH2(1,8)-NH2
Drug Alias NameCSD-CH2(1,8)-NH2
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionKappa opioid receptor antagonists
TargetsKappa opioid receptor
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedical University Of Vienna
China Registration ClassN/A

Develop Information

Active CompaniesMedical University Of Vienna
Inactive CompaniesN/A
Active IndicationsMental Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A